HOME Research Insight Expansions, Agreements and New Product Launches Are the Key Growth Strategies in the Global Protein Expression Market



Expansions, Agreements and New Product Launches Are the Key Growth Strategies in the Global Protein Expression Market


The major players in the protein expression market are Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies Corporation (U.S.), Merck Millipore (U.S.), New England Biolabs, Inc. (U.S.), Promega Corporation (U.S.), Qiagen (The Netherlands), Sigma-Aldrich Corporation (U.S.), Takara Bio, Inc. (Japan), and Thermo Fischer Scientific, Inc. (U.S.).

The protein expression market is highly consolidated in nature, with few large players dominating the entire market. Stringent regulatory requirements, dearth of innovative technologies in the field of protein expression, and a high degree of consolidation are important entry barriers for new entrants in this market. Life Technologies Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), and Thermo Fischer Scientific (U.S.) are the leaders in this market. The combined market share of these three companies far exceeds that of all the other players. Overall, about 60% of the global protein expression market was dominated by these companies, in 2013. Furthermore, acquisitions carried out by market leaders in this field have strengthened their market positions and have further consolidate the market. Thermo Fisher Scientifics’ acquisition of Life Technologies in 2014 was an important milestone as the combined market share of both the companies post acquisition exceeded 45% of the total global protein expression market.

Expansions, agreements, and new product launches were the three most important growth strategies adopted in this market. About 85% of the total strategic developments in the market between 2010 and 2013 were attributed to these strategies. The expansions and agreements strategies were mainly aimed at strengthening the position of the company in the emerging Asian markets. The companies that employed expansions and agreements as a growth strategy in this period (2010-2013) included New England BioLabs, Inc. (U.S.), QIAGEN (Netherlands), and Promega (U.S). New product launches were primarily related to the reagents, media, and cell lines required for transfection. The companies that employed new product launch strategy (2010-2013) included Life Technologies Corporation (U.S.), Merck Millipore (U.S.), and Thermo Fischer Scientific (U.S.).

Related Reports:

Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports